As Cdc42 GTPase inhibitors are a selective, reversible, non-competitive inhibitor of Cdc42 GTPases, these results indicate the possible involvement of Cdc42 in the Ln511-E8 fragment-induced enhanced adhesion of gastric cancer cells, whereas Rac1 and Rho are not or only partially involved. The gene discussed is RHO; the disease is gastric cancer.